Affiliation: Erasmus University
Country: The Netherlands
- Cost-effectiveness analysis of cataract surgery: a global and regional analysisRob Baltussen
iMTA Institute for Medical Technology Assessment, Erasmus University Rotterdam, The Netherlands
Bull World Health Organ 82:338-45. 2004..To estimate the population health effects, costs and cost effectiveness of selected cataract surgery interventions in areas of the world with different epidemiological profiles...
- Iron fortification and iron supplementation are cost-effective interventions to reduce iron deficiency in four subregions of the worldRob Baltussen
WHO CHOICE, Institute for Medical Technology Assessment, Erasmus Medical Center, Rotterdam, The Netherlands
J Nutr 134:2678-84. 2004..The results should be interpreted with caution, because evidence of intervention effectiveness predominantly relates to small-scale efficacy trials, which may not reflect the actual effect under expected conditions...
- The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan AfricaJan A C Hontelez
Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
AIDS 26:S19-30. 2012..We quantify the change in the age composition of HIV-infected people in all countries in SSA...
- Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and AsiaMartijn T Groot
Institute for Medical Technology Assessment, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands
Breast J 12:S81-90. 2006..These findings suggest that treating stage I disease and introducing an extensive breast cancer program are the most cost-effective breast cancer interventions...
- The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South AfricaJan A C Hontelez
Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands
PLoS ONE 6:e21919. 2011..Furthermore, there will be a more profound impact on HIV incidence, leading to relatively less annual costs after seven years. The resulting cumulative net costs reach a break-even point after on average 16 years...
- Cost-effectiveness analysis for priority setting in health: penny-wise but pound-foolishRob Baltussen
Institute for Medical Technology Assessment, Erasmus Medical Centre Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
Int J Technol Assess Health Care 21:532-4. 2005..Without redirecting the focus of economic evaluation research, choosing in health care bears the risk to remain penny-wise but pound-foolish...
- Accounting for the cost of scaling-up health interventionsBenjamin Johns
Global Programme on Evidence for Health Policy GPE EQC, World Health Organization, CH 1211 Geneva 27, Switzerland
Health Econ 13:1117-24. 2004..Results show changing marginal costs as predicted by economic theory...
- Cost effectiveness analysis of strategies for tuberculosis control in developing countriesRob Baltussen
Institute for Medical Technology Assessment iMTA, Erasmus Medical Centre, PO Box 1738, 3000 DR Rotterdam, Netherlands
BMJ 331:1364. 2005..To assess the costs and health effects of tuberculosis control interventions in Africa and South East Asia in the context of the millennium development goals...
- Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countriesDaniel R Hogan
Harvard Center for Population and Development Studies, Harvard School of Public Health, Cambridge, MA 02138, USA
BMJ 331:1431-7. 2005..To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS...
- Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, IndiaFilip Meheus
Institute of Development Policy and Management, University of Antwerp, Antwerp, Belgium
Trop Med Int Health 11:1715-24. 2006..To identify and quantify the direct and indirect economic cost of treatment for visceral leishmaniasis (VL) with conventional Amphotericin B deoxycholate, currently the first-line treatment in Muzaffarpur...
- Costs, health effects and cost-effectiveness of alcohol and tobacco control strategies in EstoniaTaavi Lai
Department of Public Health, University of Tartu, Estonia
Health Policy 84:75-88. 2007..To assess the population-level costs, effects and cost-effectiveness of different alcohol and tobacco control strategies in Estonia...
- Barriers to access to antiretroviral treatment in developing countries: a reviewMariana Posse
Faculty of Economics and Management, Catholic University of Mozambique, Beira, Mozambique
Trop Med Int Health 13:904-13. 2008..To present a review of barriers impeding people living with HIV/AIDS in developing countries from accessing treatment, and to make recommendations for further studies...